MDxHealth SA (MDXH) Equity Average (2021 - 2024)

MDxHealth's Equity Average history spans 4 years, with the latest figure at $11.0 million for Q4 2024.

  • For Q4 2024, Equity Average rose 33.44% year-over-year to $11.0 million; the TTM value through Dec 2024 reached $11.0 million, up 33.44%, while the annual FY2024 figure was $11.0 million, 33.44% up from the prior year.
  • Equity Average for Q4 2024 was $11.0 million at MDxHealth, up from $8.3 million in the prior quarter.
  • Across five years, Equity Average topped out at $28.1 million in Q4 2022 and bottomed at $8.3 million in Q4 2023.
  • The 4-year median for Equity Average is $18.7 million (2021), against an average of $18.4 million.
  • The largest annual shift saw Equity Average tumbled 70.61% in 2023 before it surged 33.44% in 2024.
  • A 4-year view of Equity Average shows it stood at $26.4 million in 2021, then increased by 6.57% to $28.1 million in 2022, then plummeted by 70.61% to $8.3 million in 2023, then soared by 33.44% to $11.0 million in 2024.
  • Per Business Quant, the three most recent readings for MDXH's Equity Average are $11.0 million (Q4 2024), $8.3 million (Q4 2023), and $28.1 million (Q4 2022).